Is Synopsys (SNPS) Below Fair Value On Earnings Beat Optimism?

Synopsys (SNPS) is back in focus as investors weigh upbeat expectations for the next earnings report, with a positive Earnings ESP and strong analyst consensus serving as key drivers of recent stock interest.

Over the past month Synopsys has seen a 1 month share price return of 9.46%, even as the 90 day share price return is down 22.27% and the 1 year total shareholder return has declined 31.41%, which points to improving short term momentum after a weaker stretch. Recent gains, including a 1 day share price return of 3.62% and a 7 day share price return of 1.08%, appear linked to rising optimism around an earnings beat and follow quieter corporate news flow. This includes the planned transition of General Counsel Janet Lee to an advisory role, which may slightly adjust perceptions of governance stability rather than the core earnings story.

Spot opportunities that echo Synopsys' setup around earnings with a curated list of other stocks showing resilient fundamentals and fresh momentum using our 18 high quality undiscovered gems.

Synopsys now trades below both analyst targets and an estimated fair value, even after the recent rebound. Is that simply the market pricing in risk, or an overly cautious stance that the numbers no longer support?

Most Popular Narrative: 27% Undervalued

Synopsys closed at $408.79 compared with a widely followed fair value narrative of about $559.58, which frames why sentiment around the stock is so focused on earnings delivery and integration progress.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Read the complete narrative.

Want to understand what sits behind that growth story for Synopsys? The narrative ties rich revenue assumptions, rising margins, and a premium earnings multiple into one tight valuation blueprint.

Result: Fair Value of $559.58 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Synopsys still faces execution risk around the Ansys integration and ongoing exposure to weaker performance in China. Either of these factors could challenge the upbeat earnings narrative.

Find out about the key risks to this Synopsys narrative.

Another View: Synopsys Through The P/E Lens

There is a different story if you look at Synopsys through its P/E ratio rather than future cash flows. The stock trades on about 101.2x earnings, compared with 30.8x for the US Software industry, 34.7x for peers, and a fair ratio of 53.1x that the market could move towards. That points to a valuation that embeds a lot of expectation and raises the question of how much earnings delivery is already priced in.

For a closer look at how this kind of earnings based view stacks up against other checks on Synopsys, take a look at the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Conflicted about whether Synopsys is priced for perfection or still has room to run after these moves and narratives? Move quickly to review both sides of the story by checking the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Synopsys?

If Synopsys has sharpened your focus, do not stop here. Use targeted stock ideas to round out your watchlist and avoid missing opportunities that fit your approach.

• Target resilient cash generators by checking companies that screen well on balance sheet strength and fundamentals using the list of solid balance sheet and fundamentals (51 results).
• Hunt for potential value candidates that pair quality metrics with appealing pricing by reviewing the 49 high quality undervalued stocks.
• Prioritize stability and income by scanning stocks that offer higher yields with robust profiles through the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com